EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Extended Genotyping as Triage of HPV Positive Screened Women in Low‐and‐Middle Income Countries

Frederick H van der Merwe iD, Greta Dreyer iD, Cathy Visser iD, Gerrit J Dreyer, Karin Richter iD, Leon C Snyman iD, Robyn Adams iD, Matthys H Botha iD

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.70981 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Frederick H van der Merwe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gynaecologic Oncology Unit, Department of Obstetrics and Gynaecology, Stellenbosch University, Stellenbosch, South Africa. Hauptthemen laut MEDLINE: Early Detection of Cancer, Genotyping Techniques, Human Papillomavirus Viruses, Papillomaviridae. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cepheid.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer screening coverage in low‐ and middle‐income countries is low, and many screened women are lost to follow‐up. Point‐of‐care testing that allows same‐day treatment could reduce the incidence of this cancer, but same‐day triage testing is required to prevent overtreatment and minimise loss‐to‐follow‐up before treatment. Built‐in extended genotyping with the Xpert® human papilloma virus (HPV) assay offers point‐of‐care triage, but treatment thresholds differ. We calculated test performance of the Xpert® HPV assay for HIV‐positive and HIV‐negative women. Extended HPV‐genotyping was evaluated against histology and missing values were imputed to correct for verification bias. We report test performance at different thresholds, namely Top3 (HPV16, 18, 45), Top8 (HPV16, 18, 45, 31, 33, 35, 52, 58) and Top14 (HPV16, 18, 45, 31, 33, 35, 52, 58, 51, 59, 39, 56, 66, 68) hierarchical viral types. Included were 1063 participants, aged 25–65 years, mean age 41.2 years; 42.7% were HIV‐positive. HIV‐positive women were significantly more likely to test positive on multiple test channels and were more likely to have histology proven disease. Screening only for Top3, sensitivity (CIN3+) was 31.3%/41.5%, and specificity (CIN2+) 97.0%/95.6% for HIV‐negative/HIV‐positive women respectively. Top8 rendered results of 57.8%/76.4% and 91.8%/84.6% respectively, which is acceptable for a triage test. Treatment at the threshold of Top8 types requires less than three referrals among all HIV‐groups for one case of histology proven disease. Results confirmed screening for all 14 high‐risk HPV types is most sensitive but necessitates triage. Extended genotyping using a threshold of Top8 oncogenic types rendered best balance of sensitivity and specificity and overall test performance for both HIV‐groups in a test‐and‐treat strategy. Clinical Trial Registration The study was registered as Trial ID NCT02956031 on ClinicalTrials. gov.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerGenotyping TechniquesHuman Papillomavirus VirusesPapillomaviridaePapillomavirus InfectionsTriageUterine Cervical NeoplasmsAdultAgedFemaleHumansMiddle AgedDeveloping CountriesGenotypeHIV InfectionsMass ScreeningSensitivity and Specificity

Stichwörter der Autor:innen

HPV DNA test performancecervical cancer screeningextended HPV genotypinghuman immunodeficiency virushuman papillomavirus infection

Autor:innen und Institutionen

  • Gynaecologic Oncology Unit, Department of Obstetrics and Gynaecology, Stellenbosch University, Stellenbosch, South Africa.
  • Gynaecologic Oncology Unit, Department of Obstetrics and Gynaecology, University of Pretoria, Pretoria, South Africa.
  • Department of Statistics and Actuarial Science, Stellenbosch University, Stellenbosch, South Africa.
  • Department of Medical Virology, University of Pretoria, Pretoria, South Africa.

ORCID-Profile: Frederick H van der Merwe, Greta Dreyer, Cathy Visser, Karin Richter, Leon C Snyman, Robyn Adams, Matthys H Botha

Förderung

  • Cepheid

Zitieren

APA

van der Merwe, F. H., Dreyer, G., Visser, C., Dreyer, G. J., Richter, K., Snyman, L. C., Adams, R., & Botha, M. H. (2026). Extended Genotyping as Triage of HPV Positive Screened Women in Low‐and‐Middle Income Countries. Journal of Medical Virology. https://doi.org/10.1002/jmv.70981

Vancouver

van der Merwe FH, Dreyer G, Visser C, Dreyer GJ, Richter K, Snyman LC, et al. Extended Genotyping as Triage of HPV Positive Screened Women in Low‐and‐Middle Income Countries. Journal of Medical Virology. 2026. doi:10.1002/jmv.70981

BibTeX
@article{vanderMerwe2026,
  author = {van der Merwe, Frederick H and Dreyer, Greta and Visser, Cathy and Dreyer, Gerrit J and Richter, Karin and Snyman, Leon C and Adams, Robyn and Botha, Matthys H},
  title = {Extended Genotyping as Triage of HPV Positive Screened Women in Low‐and‐Middle Income Countries},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.70981}
}
Kostenlos starten →